Hedwig van Hove

Toxicity of anticancer drugs in human placental tissue explants and trophoblast cell lines

Gaby A.M. Eliesen, Hedwig van Hove, Maartje H. Meijer et al. · Archives of Toxicology · 2020 · 30 citations · Full text

Medicine, Oncology, Pharmacology +12

Assessment of Placental Disposition of Infliximab and Etanercept in Women With Autoimmune Diseases and in the <i>Ex Vivo</i> Perfused Placenta

Gaby A.M. Eliesen, J. van Drongelen, Hedwig van Hove et al. · Clinical Pharmacology & Therapeutics · 2020 · 29 citations · Full text

Life Sciences, Immunology, Obstetrics +11

Prediction of Maternal and Fetal Doravirine Exposure by Integrating Physiologically Based Pharmacokinetic Modeling and Human Placenta Perfusion Experiments

Vera E. Bukkems, Hedwig van Hove, Damian Roelofsen et al. · Clinical Pharmacokinetics · 2022 · 19 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Optimization of the betamethasone and dexamethasone dosing regimen during pregnancy: a combined placenta perfusion and pregnancy physiologically based pharmacokinetic modeling approach

Joyce E. M. van der Heijden, Hedwig van Hove, Niki M Van Elst et al. · American Journal of Obstetrics and Gynecology · 2024 · 15 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +16

Predicting fetal exposure of crizotinib during pregnancy: Combining human ex vivo placenta perfusion data with physiologically-based pharmacokinetic modeling

Damian Roelofsen, Hedwig van Hove, Vera E. Bukkems et al. · Toxicology in Vitro · 2022 · 13 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17